Community-engaged Hypertension Prevention Program in Black Men

Sponsor
NYU Langone Health (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05447962
Collaborator
American Heart Association (Other)
420
1
2
38
11

Study Details

Study Description

Brief Summary

The CLIP program will train Community Health Workers (CHWs) to screen and identify Black men with elevated blood pressure (BP) or stage 1 hypertension (HTN), initiate lifestyle counseling; and link them to primary care and social services.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP)
  • Behavioral: Barbershop-Based Facilitation (BF)
N/A

Detailed Description

The study will consist of:
  1. An implementation phase that will use a cluster randomized cluster trial of 20 barbershops among Black men with elevated BP or Stage 1 HTN, to compare the effect of the Barbershop-based Facilitation (BF) strategy (n=10 barbershops; n=210 participants) vs. self-directed control (i.e. receipt of information for implementation of CLIP without the BF strategy; n=10 barbershops; n=210 participants), on BP reduction, HTN prevention, linkage to care, and adoption of CLIP at 12 months

  2. A post-implementation phase that will use Reach Effectiveness Adoption Implementation and Maintenance (RE-AIM) to evaluate the effect of the BF strategy versus self-directed control on sustainability of CLIP 6 months after completion of the trial; and cost-effectiveness over a 10-year time horizon.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
420 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Community-engaged Implementation Study of Hypertension Prevention and Navigation in Black Men
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2025
Anticipated Study Completion Date :
Sep 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: Barbershop-Based Facilitation (BF)

Participants will receive the Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP) program manual and receive exposure to Barbershop-Based Facilitation (BF), which is designed to stimulate specific, actionable steps that community health workers (CHWs) can undertake to implement CLIP at the barbershop.

Behavioral: Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP)
Multilevel intervention designed to mitigate adverse social determinants of health (SDoH) via linkage to care, health system navigation, and referral to social services.

Behavioral: Barbershop-Based Facilitation (BF)
Trained and qualified facilitators assist community health workers (CHWs) to: 1) increase their confidence in delivering CLIP; 2) understand participants' concerns and beliefs about hypertension (HTN); and 3) develop skills in lifestyle counseling to help the men initiate lifestyle modification.

Active Comparator: Self-Directed

Participants will receive the Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP) program manual.

Behavioral: Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP)
Multilevel intervention designed to mitigate adverse social determinants of health (SDoH) via linkage to care, health system navigation, and referral to social services.

Outcome Measures

Primary Outcome Measures

  1. Change in Systolic Blood Pressure (SBP) Levels [Baseline, Month 12]

    All participants will have office blood pressure (BP) measured on their non-dominant arm with an Omron HEM-907XL BP device. 3 BP readings separated by one minute will be obtained at each visit. The 3 BP readings will be averaged to obtain mean BP. SBP Levels are classified as follows: Normal: Below 120 millimeters of mercury (mm Hg) Elevated: 120-129 mm Hg Stage 1 hypertension: 130-139 mm Hg Stage 2 hypertension: 140 mm Hg or more Hypertensive crisis: 180 mm Hg or more

Secondary Outcome Measures

  1. Change in Diastolic Blood Pressure (DBP) Levels [Baseline, Month 12]

    All participants will have office blood pressure (BP) measured on their non-dominant arm with an Omron HEM-907XL BP device. At each visit, 3 BP readings separated by one minute will be obtained. The 3 BP readings will be averaged to obtain study BP. DBP Levels are classified as follows: Normal: Lower than 80 millimeters of mercury (mm Hg) Stage 1 hypertension: 80-89 mm Hg Stage 2 hypertension: 90 mm Hg or more Hypertensive crisis: 120 mm Hg or more.

  2. Number of Participants Presenting to Referral Clinics within 3 Months of Community Health Worker (CHW) Referral [Baseline]

    Measurement of linkage to care. Data will be gathered via telephone interview or during barbershop visit.

  3. Number of Participants Presenting to Referral Clinics within 3 Months of Community Health Worker (CHW) Referral [Month 6]

    Measurement of linkage to care. Data will be gathered via telephone interview or during barbershop visit.

  4. Number of Participants Presenting to Referral Clinics within 3 Months of Community Health Worker (CHW) Referral [Month 12]

    Measurement of linkage to care. Data will be gathered via telephone interview or during barbershop visit.

  5. Number of Participants Presenting to Referral Clinics within 3 Months of Community Health Worker (CHW) Referral [Month 18]

    Measurement of linkage to care. Data will be gathered via telephone interview or during barbershop visit.

  6. Number of Barbershops Completing all Components of CLIP [Month 12]

    Measurement of the rate of adoption of Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP).

  7. Number of Barbershops Continuing to Use CLIP at 6 Months Post-Completion of Intervention [Month 18]

    Measurement of the sustainability of Community-to-Clinic Linkage Implementation Program in Barbershops (CLIP).

  8. Number of Participants Presenting with Incident Stage 2 HTN [Baseline]

    Incident Stage 2 hypertension (HTN) is defined as: Systolic Blood Pressure (SBP) of at least 140 millimeters of mercury (mm Hg)/Diastolic Blood Pressure (DBP) of at least 90 mm Hg; or Antihypertensive medication initiation.

  9. Number of Participants Presenting with Incident Stage 2 HTN [Month 6]

    Incident Stage 2 hypertension (HTN) is defined as: Systolic Blood Pressure (SBP) of at least 140 millimeters of mercury (mm Hg)/Diastolic Blood Pressure (DBP) of at least 90 mm Hg; or Antihypertensive medication initiation.

  10. Number of Participants Presenting with Incident Stage 2 HTN [Month 12]

    Incident Stage 2 hypertension (HTN) is defined as: Systolic Blood Pressure (SBP) of at least 140 millimeters of mercury (mm Hg)/Diastolic Blood Pressure (DBP) of at least 90 mm Hg; or Antihypertensive medication initiation.

  11. Number of Participants Presenting with Incident Stage 2 HTN [Month 18]

    Incident Stage 2 hypertension (HTN) is defined as: Systolic Blood Pressure (SBP) of at least 140 millimeters of mercury (mm Hg)/Diastolic Blood Pressure (DBP) of at least 90 mm Hg; or Antihypertensive medication initiation.

  12. 12-Item Short Form Survey (SF-12) Questionnaire Score [Baseline]

    The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality-of-life measure. SF-12 consists of 12 questions that are scored in various ways. The total score range is 12-48; the higher the score, the better the physical and mental health functioning.

  13. 12-Item Short Form Survey (SF-12) Questionnaire Score [Month 6]

    The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality-of-life measure. SF-12 consists of 12 questions that are scored in various ways. The total score range is 12-48; the higher the score, the better the physical and mental health functioning.

  14. 12-Item Short Form Survey (SF-12) Questionnaire Score [Month 12]

    The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality-of-life measure. SF-12 consists of 12 questions that are scored in various ways. The total score range is 12-48; the higher the score, the better the physical and mental health functioning.

  15. 12-Item Short Form Survey (SF-12) Questionnaire Score [Month 18]

    The SF-12 is a self-reported outcome measure assessing the impact of health on an individual's everyday life. It is often used as a quality-of-life measure. SF-12 consists of 12 questions that are scored in various ways. The total score range is 12-48; the higher the score, the better the physical and mental health functioning.

  16. Cost per Millimeters of Mercury (mm Hg) Reduction in Blood Pressure (BP) [Up to Month 18]

    Dollar amount associated with a 1-mm Hg reduction in BP. Lower costs are considered more desirable outcomes.

  17. Cost per Incident Stage 2 Hypertension (HTN) Case Prevented [Up to Month 18]

    Dollar amount associated with the prevention of an Incident Stage 2 HTN case. Lower costs are considered more desirable outcomes. Incident Stage 2 HTN is defined as: Systolic Blood Pressure (SBP) of at least 140 millimeters of mercury (mm Hg)/Diastolic Blood Pressure (DBP) of at least 90 mm Hg; or Antihypertensive medication initiation.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 85 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. 18 years of age as of date of data extraction

  2. Repeat customer within the last 3 months

  3. Self-identify as Black

  4. Self-identify as male

  5. Have elevated blood pressure (PB) (120-129/<80 millimeters of mercury (mm Hg)) or untreated stage 1 hypertension (HTN) (130-139/80-89 mm Hg) (defined by American Heart Association's 2017 HTN clinical guidelines)

Exclusion Criteria:
  1. Age <18 years

  2. Prescribed antihypertensive medication

  3. Diagnosis of end-stage renal disease (ESRD)

  4. Condition which interferes with outcome measurement (e.g., dialysis)

  5. Serious medical condition which either limits life expectancy or requires active management (e.g., cancer)

  6. Cognitive impairment or other condition preventing participation in the intervention

  7. Upper arm circumference >50 cm (maximum limit of the extra-large BP cuff)

  8. Active alcohol or substance use disorder (i.e., not sober/abstinent for ≥ 30 days)

  9. Pregnant or planning pregnancy in the next 24 months

  10. Currently nursing a child

  11. Current participation in another research study focused on reducing BP

  12. Unwillingness to provide informed consent

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health
  • American Heart Association

Investigators

  • Principal Investigator: Joseph Ravenell, MD, NYU Langone Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT05447962
Other Study ID Numbers:
  • 21-01586
First Posted:
Jul 7, 2022
Last Update Posted:
Jul 7, 2022
Last Verified:
Jul 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by NYU Langone Health
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 7, 2022